The neuroprotective steroid progesterone promotes mitochondrial uncoupling, reduces cytosolic calcium and augments stress resistance in yeast cells

Abstract

The steroid hormone progesterone is not only a crucial sex hormone, but also serves as a neurosteroid, thus playing an important role in brain function. Epidemiological data suggest that progesterone improves the recovery of patients after traumatic brain injury. Brain injuries are often connected to elevated calcium spikes, reactive oxygen species (ROS) and programmed cell death affecting neurons. Here, we establish a yeast model to study progesterone-mediated cytoprotection. External supply of progesterone protected yeast cells from apoptosis-inducing stress stimuli and resulted in elevated mitochondrial oxygen uptake accompanied by a drop in ROS generation and ATP levels during chronological aging. In addition, cellular Ca²⁺ concentrations were reduced upon progesterone treatment, and this effect occurred independently of known Ca²⁺ transporters and mitochondrial respiration. All effects were also independent of Dap1, the yeast orthologue of the progesterone receptor. Altogether, our observations provide new insights into the cytoprotective effects of progesterone.

INTRODUCTION

Progesterone is a sterol-derived hormone that is crucial for female reproductive capacity and plays major regulatory roles in the monthly menstrual cycle and upon conception as well as during pregnancy and embryogenesis. In addition, it also serves as a neurosteroid, thus playing an important role in brain function in both sexes 1. For instance, progesterone inhibits the neuronal nicotinic acetylcholine receptor and stimulates the synthesis of myelin proteins 1. Of note, progesterone has been linked to the gender-specific risk and outcome of brain injuries that is more favorable for females 2. Interestingly, preclinical data strongly suggest that (high doses of) progesterone may positively affect recovery from traumatic brain injury (TBI) in model organisms 3,4,5,6,7, if administered before or shortly after TBI. Two clinical studies could confirm a neuroprotective effect of progesterone when administered shortly after TBI 8,9, while some more recent clinical data seem to disprove this hypothesis 10,11,12. Therefore, it remains an open question if progesterone affects the recovery and survival after TBI in humans and to which extent it promotes cellular restauration.

In order to investigate the cytoprotective potential of progesterone, we took advantage of Saccharomyces cerevisiae, knowing that this organism has repeatedly been shown to be suitable for mechanistic studies of programmed cell death (PCD) 13,14,15,16,17,18,19. Yeast is especially useful as a model to study neuroprotection at the cellular level 20,21,22,23,24,25,26,27. Here, we describe the positive impact of progesterone on several parameters of cellular physiology. Importantly, our results also suggest a possible receptor-independent mechanism for these effects, since deletion of DAP1 - a heme-binding protein related to the mammalian membrane progesterone receptor - did not alter susceptibility towards progesterone treatment. Altogether, we reveal that progesterone exerts potent cytoprotective effects in yeast.

RESULTS

Progesterone increases stress tolerance

Traumatic brain injury is connected to elevated PCD and ROS accumulation in the brain tissue 28,29. Therefore, we tested if progesterone would render yeast cells less susceptible towards different stressors that are connected to an increase in ROS production. Upon addition of progesterone, wild type yeast cultures treated with H₂O₂ or acetate, which are both well-known PCD inducers in yeast 14,30,31,32,33,34, showed reduced ROS accumulation as measured by the ROS-driven conversion of dihydroethidium (DHE) to fluorescent ethidium (Figure 1A and B). Furthermore, under physiological culture conditions, in the absence of PCD inducers, progesterone significantly reduced ROS levels as compared to the untreated control (Figure 2A). Altogether, progesterone dampens ROS production in yeast, both in normal culture conditions and in the presence of external stress factors.

Figure 1. FIGURE 1: Progesterone treatment increases resistance of wildtype yeast to external stressors.

ROS accumulation in yeast cells treated with progesterone (10 µg/ml) or left untreated as shown by the DHE to ethidium turnover rate upon hydrogen peroxide (A) or acetate (B) challenge during logarithmic phase. All data represent mean values (n = 3 ± SEM). Statistical analysis was conducted using non-paired Student’s t-test. * = p<0.05; ** = p<0.01; *** = p<0.001; n.s. = non-significant, Prog = progesterone, ctrl = control.

Progesterone impacts mitochondria by acting as a mild respiration-uncoupler

To further explore the mechanisms underlying progesterone cytoprotection, we next examined the physiology of mitochondria, since these organelles constitute one of the main sources of ROS 35,36,37,38. Interestingly, while O₂ consumption was significantly enhanced during progesterone treatment, ATP levels were reduced (Figure 2B and C). Altogether, this indicates an uncoupling phenotype with diminished oxidative phosphorylation. Accordingly, we observed reduced growth of wild type yeast upon progesterone treatment on a non-fermentable carbon source (glycerol), while no changes were detected on a fermentable carbon source (glucose) (Figure 2D and E). Importantly, this effect was also observed in a mutant strain lacking the heme-binding protein Dap1, which is the sole yeast orthologue of the human progesterone receptor (Figure 2D and E) 39. Furthermore, we could demonstrate that stress protection by progesterone is respiration-dependent, since progesterone treatment did not confer stress resistance in respiration-deficient rho⁰ cells (Figure 2F). Altogether, it appears that progesterone impacts yeast mitochondrial respiration in a receptor-independent fashion.

Figure 2. FIGURE 2: Progesterone impacts energy metabolism and reduces oxygen stress accumulation in wildtype yeast.

Wildtype yeast were treated with 10 µg/ml progesterone and assayed for (A) ROS accumulation via DHE to ethidium turnover, (B) oxygen consumption via respirometry, and (C) ATP production. Growth curves of wildtype as well as ∆dap1 strains, with or without progesterone treatment, on glycerol (respiratory carbon source) (D) and glucose (fermentative carbon source) media (E). ROS accumulation in rho⁰ yeast cells +/- progesterone (10 µg/ml) treated or untreated with H₂O₂ or acetate during logarithmic phase (F). All data represent mean values (n = 3-5 ± SEM). Statistical analysis was conducted using non-paired Student t-test (A-C, F) or using a two-way repeated measurement ANOVA and multiple comparison post-hoc Tukey’s test (D, E). * = p<0.05; ** = p<0.01; *** = p<0.001; n.s. = non-significant. ROS = reactive oxygen species, rFU = relative fluorescence units, Prog = progesterone, ctrl = control.

Progesterone administration diminishes cytosolic Ca²⁺ concentrations both under physiological as well as under high calcium conditions

Next we investigated progesterone effects on Ca²⁺ homeostasis, knowing that mitochondria are one of the organelles responsible for buffering cytosolic Ca²⁺ under normal conditions 40. Importantly, TBI, stroke, and even some forms of dementia cause Ca²⁺ accumulation in the cytosol of neurons followed by cell death and neurodegeneration 41. Thus, we examined the capacity of yeast cells to process Ca²⁺ uptake under the influence of progesterone. Specifically, wild type yeast cell cultures were challenged with 150 mM CaCl₂ and transient concentrations of cytoplasmic Ca²⁺ levels ([Ca²⁺]cyt) / responses were monitored. Progesterone caused a significantly reduced Ca²⁺ uptake capacity alongside with a faster reduction of cytoplasmic Ca²⁺ levels (Figure 3A and B). Of note, basal Ca²⁺ levels before and after the Ca²⁺ pulse were already lowered when cells were treated with progesterone (Figure 3B). However, mitochondrial respiration was not involved in this phenotype, since progesterone treatment continued to affect basic cytosolic Ca²⁺ levels in respiration-deficient rho⁰ cells (Figure 3C and D).

Figure 3. FIGURE 3: Cellular Ca²⁺ homeostasis is modulated by progesterone treatment in yeast.

Cells were treated with progesterone (10 µg/ml) and challenged with high doses of Ca²⁺ (150 mM). Intake of Ca²⁺ as well as Ca²⁺-clearance in the cytosol to its basal level were measured in wild type (A,B), a DAP1-deletion strain (C,D), as well as in a rho⁰ strain, incapable of mitochondrial respiration (E,F). Data are shown as mean values of at least three replicates including the standard error of the mean. Statistical analysis was conducted using non-paired Student’s t-test. * = p<0.05; ** = p<0.01; *** = p<0.001; n.s. = non-significant. E_max = global maximum of the respective ethanol-treated control; rLU = relative luminiscence units, Prog = progesterone, ctrl = control.

To further investigate the observed phenotypes, we tested single-gene deletion mutants of all currently known Ca²⁺ channels/transporters in yeast, including the cytoplasmic membrane transporters Cch1 and Mid 1, the organelle transporters Vcx1, Pmr1, Cod1, Yvc1, and Pmc1 as well as Emc7, an ER protein associated to Ca²⁺ homeostasis. Although Ca²⁺ uptake and clearance was influenced by some of these gene deletion, all mutants continued to exhibit significantly reduced Ca²⁺ uptake when treated with progesterone (compare Supplemental Figure 1A-G to H). Thus, the effects observed in wild type cells could not be reversed by single gene deletions in any of these transporters. Similarly, the effects of progesterone treatment on Ca²⁺ homeostasis/uptake were independent of the mammalian membrane progesterone receptor homolog Dap1 (Figure 3E and F). Taken together, progesterone seems to influence Ca²⁺ homeostasis/uptake in a general manner, independently from known Ca²⁺ transporters and respiration capacity.

DISCUSSION

Here, we establish S. cerevisiae as a model to investigate cytoprotection by progesterone. We observed that progesterone increased stress tolerance of yeast to the well-known PCD inducers H₂O₂ and acetate 14,30,31,32,33,34 as well as under physiological (control) conditions. Interestingly, progesterone treatment led to a mild uncoupling phenotype with higher O₂ consumption (+50%) but lower ATP levels (-50%), arguing for a mitochondrial uncoupling effect. Indeed, growth on the non-fermentable carbon source glycerol was diminished in the presence of progesterone. Notably, mild uncoupling induced by chemical substances (such as dinitrophenol), caloric restriction or ectopic expression of mammalian uncoupling proteins in yeast - S. cerevisiae does not possess any known uncoupling proteins 42 - is known to increase lifespan 43,44,45. Similarly, in mammalian aging cells, changes in mitochondrial energy metabolism caused by mitochondrial uncoupling seem to improve cellular fitness 46. Progesterone treatment of human cells has been demonstrated to strongly increase the levels of mRNAs coding for uncoupling proteins 47. Increased O₂ consumption with decreased ³²P uptake (as a parameter for ATP production) has been reported for isolated rat mitochondria treated with progesterone 48. Collectively, our data combined with those reported in the literature highlight the possibility to investigate progesterone-mediated effects in the yeast model. The uncoupling aspect of progesterone, in fact, could represent one of the mechanisms of neuroprotection conferred by this steroid. In fact, the stress tolerance of a respiration-deficient rho⁰ strain was not influenced by progesterone treatment.

Progesterone had major effects on Ca²⁺ homeostasis and, in particular, on Ca²⁺ susceptibility/uptake. However, we could not identify any single Ca²⁺ channel in yeast that would influence these effects. However, we cannot exclude that yet unidentified Ca²⁺ channels or a combinations of known Ca²⁺ channels mediate these effects 49. Another possible mode of action of progesterone on Ca²⁺ homeostasis could reside in its direct interaction with biological membranes. Since the chemical structure of progesterone shows four-ring as well as hydrophobic backbone and polar groups at both ends of the molecule, it could directly interact with cellular and mitochondrial membranes 50 and possibly influence their permeability towards inorganic cations (e.g. Ca²⁺, H⁺). This mode of action could connect our observations of mitochondrial uncoupling and modulation of Ca²⁺ homeostasis. Of note, a progesterone-treated rho⁰ strain still showed Ca²⁺ effects but no enhanced stress tolerance, suggesting that altered Ca²⁺ homeostasis may lie upstream of mitochondrial uncoupling. However, these mechanistic hypotheses remain to be empirically tested.

Certainly, the putative relevance of the herein described progesterone effects for TBI pathology remains to be explored. In some mammalian cell types, progesterone leads to a significant increase of intracellular Ca²⁺ 51,52, partly by activating protein kinase C 53 and depleting endocannabinoids by activating α/β hydrolase domain-containing protein 2 (ABHD2) 54. However, in other cell types, progesterone withdrawal leads to an increased level of cytosolic Ca²⁺ 55. While progesterone was not able to reduce estrogen-induced Ca²⁺ uptake in the rabbit myometrial smooth muscle cells, it increased the accumulation of Ca²⁺ in mitochondria 55. This suggests that progesterone withdrawal reduces both myometrial cytosolic Ca²⁺ levels as well as the capacity of these cells to accumulate Ca²⁺in different cellular compartments. Similar effects were reported for other types of smooth muscles 56,57 and are believed to be caused by regulation of the inward current through L-type Ca²⁺ channels 56,58. In neurons, the influence on Ca²⁺ signaling and the following inhibition of excitotoxic neuron death seem to be the neuroprotective mechanism induced by acute administration of progesterone after various neuronal injuries 59,60,61. Indeed, progesterone might mediate broad neuroprotective effects, not only in the context of TBI but also in other pathologies 62,63.

The role of progesterone in the pathological development of TBI has been well described in recent years. It has been shown that progesterone improves the function of the blood-brain-barrier after TBI 64. Progesterone also increases the level of circulating endothelial cells, which in turn improves neovascularization and vascular remodeling in the brain 65. Furthermore, progesterone treatment reduces neuroinflammation and oxidative stress 66 as it improves remyelination and functional recovery 63.

Interestingly, the intracellular effects exerted by progesterone in our model - reduced intracellular Ca²⁺ levels, uncoupled mitochondria and ROS reduction - were not lost when the sole possible yeast orthologue of the human progesterone receptor was removed from the system. This suggests that progesterone mediates its broad cytoprotective effects through other proteins than steroid receptors or perhaps with cellular membrane lipids. We surmise that yeast constitutes an ideal platform for exploring these effects in further detail.

MATERIALS AND METHODS

Growth conditions

S. cerevisiae strains (Table 1) were inoculated to 5*10⁵ (for growth curve OD₆₀₀ of 0.05) cells in SC medium containing 0.17% yeast nitrogen base (BD Diagnostics; without ammonium sulfate and amino acids), 0.5% (NH₄)₂SO₄ , 30 mg/L of all amino acids (except 80 mg/L histidine and 200 mg/L leucine), 30 mg/L adenine, and 320 mg/L uracil with 2% glucose (SCD) or alternatively with 3% glycerol (SCGly), w/o treatment with progesterone (10 µg/ml; Sigma Aldrich, Catalogue Nr. P0130). Controls were treated with respective solvent (EtOH). Where indicated, stress (acetate or H₂O₂) was inflicted as described previously in mid-log phase (~ 6h of growth, culture density 2-4*10⁶ cells/ml). Due to the inherent reduced respiration-rate of BY4741 strains, TB50a strains were used for respiration-related experiments. DAP1 deletion was carried out by classical homologous recombination 67,68.

Table 1.

Strains used in this study.

Strain	Genotype	Reference
TB50a wild type	MATa; leu2-3,112 ura3-52 trp1 his3 rme1 HMLa	69
TB50a ∆dap1	MATa; leu2-3,112 ura3-52 trp1 his3 rme1 HMLa dap1::kanMX	This study
BY4741 wild type	MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0	Euroscarf
BY4741 ∆dap1	MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 dap1::kanMX	Euroscarf
BY4741 ∆cch1	MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 cch1::kanMX	Euroscarf
BY4741 ∆mid1	MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 mid1::kanMX	Euroscarf
BY4741 ∆vcx1	MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 vcx1::kanMX	Euroscarf
BY4741 ∆pmr1	MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 pmr1::kanMX	Euroscarf
BY4741 ∆cod1	MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 cod1::kanMX	Euroscarf
BY4741 ∆yvc1	MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 yvc1::kanMX	Euroscarf
BY4741 ∆pmc1	MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 pmc1::kanMX	Euroscarf
BY4741 ∆emc7	MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 emc7::kanMX	Euroscarf

Growth curve

Cells from ONC in SCD media were inoculated to an OD₆₀₀ of 0.05 in SCD media and SCGly media with or without 10 µg/ml progesterone addition. Untreated cultures were supplemented with 0.1% EtOH for solvent control. To obtain growth curves, 300 µl of respective cultures per well were transferred into Honeycomb^® plates, and measured with Bioscreen C MBR system (Oy Growth Curves Ab Ltd.) for a period of 48 hours at 28°C, using continuous shaking and OD₆₀₀ measurements every 30 minutes.

Oxygen consumption measurement

Oxygen consumption was measured using a FireSting oxygen electrode (Pyro-Science) under constant stirring at a temperature of 28.0 ± 0.2°C in sealed 2 ml bottles. The corresponding cell counts were measured using a CASY Cell Counter, whereas percentage of living cells in the sample were established by flow cytometry with propidium iodide (PI: 100 ng/ml) stained samples. The slope of the oxygen concentration as the function of time in its linear region was calculated and normalized to the number of living cells in the sample.

ROS accumulation (DHE) assay

Oxidation of non-fluorescent di-hydroethidium (DHE) to fluorescent ethidium was used to measure ROS accumulation in yeast cells 38. Approximately 5*10⁶ cells from each sample were collected, washed and incubated with DHE solution (2.5 µg/ml in PBS) for 10 min in the dark. After washing samples were re-suspended in PBS buffer and measured using flow cytometry. The relative mean fluorescence measured for the cell population was used for analysis 70.

Boiling ethanol extraction of ATP and ATP measurement

ATP extraction was done with flash-frozen cells by adding 0.5 ml preheated (90°C) BES buffer and incubation at 90°C for 3 minutes. After centrifugation, supernatants were stored at -80°C until the measurement. ATP levels were determined by using the ATP detection kit from Invitrogen in a Luminoskan (Thermo Scientific).

Cytosolic Ca²⁺ measurements

[Ca²⁺]cyt were measured using yeast strains carrying the vector pYX212 encoding the bioluminescent protein aequorin under the control of a TPI promoter. For analysis of the cellular response to high doses of external Ca²⁺, an equivalent of 6*10⁶ cells was harvested, resuspended in 200 μl SCD containing 4 μM coelenterazine and incubated for 1 h in the dark. After washing cells were measured in a Luminoskan for 10 s and then challenged with high dose of Ca²⁺ (pump injection of 150 mM Ca²⁺). Kinetics were recorded over 120 s. The luminescence signal was normalized to the OD₆₀₀ of each well and reported in relative luminescence units, normalized to the global maximum value of the ethanol treated control of the respective run for better comparability.

SUPPLEMENTAL MATERIAL

All supplemental data for this article are also available online at "http://microbialcell.com/researcharticles/the-neuroprotective-steroid-progesterone-promotes-mitochondrial-uncoupling-reduces-cytosolic-calcium-and-augments-stress-resistance-in-yeast-cells/".

Funding Statement

We thank Silvia Dichtinger for technical assistance. FM is grateful to the Austrian Science Fund FWF (Austria) for grants P23490-B20, P29262, P24381, P29203 P27893, I1000 and ‘SFB Lipotox’ (F3012), as well as to BMWFW and the Karl-Franzens University for grant ‘Unkonventionelle Forschung’ and grant DKplus Metabolic and Cardiovascular Diseases (W1226). We acknowledge support from NAWI Graz and the BioTechMed-Graz flagship project “EPIAge”. GK is supported by the Ligue contre le Cancer Comité de Charente-Maritime (équipe labelisée); Agence National de la Recherche (ANR) - Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC); Cancéropôle Ile-de-France; Institut National du Cancer (INCa); Inserm (HTE); Institut Universitaire de France; Fondation pour la Recherche Médicale (FRM); the European Commission (ArtForce); the European Research Council (ERC); Fondation Carrefour; the LeDucq Foundation; the LabEx Immuno-Oncology; the RHU Torino Lumière, the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM); and the Paris Alliance of Cancer Research Institutes (PACRI).